Tag Archives: Gouge stitches
Nuggets medical information
.jpg "Gouge stitches")
Healthcare information technology provider of electronic medical records front of the first capital of the spring harvest, and gradually spread to attract the hospital information system construction. Break the cocoon of the market, not only Kingdee, UF set off a new round of merger integration, Huawei has different troops broke into.
Through telemedicine, doctors successfully Xinjiang Shanghai implemented a surgical patient; PLA 309 hospital doctors, by logging iPad mobile workstation, Taking command of a sudden comatose patient with rescue; iPad Drchrono service provider of electronic medical records to obtain Since DST founder Yuri Milner, including Russia (Yuri Milner), including 65 million investment; One Medical Clinic with the U.S. chain of information technology to bring cost advantages and economies of scale, smooth five rounds of financing.
These seemingly unrelated to the appearance, but point to the same trend: the most difficult nut to health care information technology field, beginning to achieve loose situation. From a single class of medical IT service providers access to venture capital favored to grab the software Gangster cloud services, hospital care market intelligence, moving from the top three hospitals have upgraded working system, to the local government to promote the social integration of the various measures of medical information systems medical information of the parties involved become clear, the production chain are increasingly forming the upper and lower ring. As the market supply and demand in the gradual and effective docking, the hospital\\ s profit model is expected to improve, and in the local government\\ s boost, the software service providers will grow faster and open space.
Force first electronic medical records
The first step in medical information, the promotion of electronic medical records through electronic health records, not only the patient\\ s condition and the treatment itself effectively track record preservation, but also significantly reduce the workload of doctors and hospitals to facilitate the timely diagnosis. Value of information surrounding the development of electronic medical records, many stakeholders, including patients, clinicians, hospital administrators, community health, medical insurance, public health, health administrators, research institutions, are expected to benefit, and telemedicine, separated diagnostics and other areas of large-scale space applications or can be synchronized to achieve a breakthrough. In addition, the wider social benefits of electronic medical records is based on the format of a unified electronic medical record, the government can use information and business systems platform interoperability, data exchange and business collaboration, and dynamic management of the health of residents, \"Poison milk \"and other similar public health emergencies will be possible early in the outbreak was discovered through an early warning system.
In foreign markets, many independent start-up company is positioned as electronic medical records service provider. Because the entry point at the front of the medical information industry chain, earnings outlook is relatively clear, its capital is also an olive branch after another. Headquartered in Silicon Valley DrChrono, with iPad platform provides electronic medical services, free version of the application can achieve a variety of functions: allows users to enter electronic medical records, arranging patient appointments, oral disease converted to text notes and photographs and video, writing and sent to the diagnosis pharmacies, etc., in order to reduce the workload of doctors; and value-added version of the charges which, for the hospital to provide greater storage capacity and medical billing and other functions.
DrChrono founded in February 2011 when the receive $ 675,000 in seed money, and later received the well-known incubator Y Combinator funding agencies. Founded in 2007, another of Practice Fusion, business is also a cloud to doctors electronic medical records, including records visits information, see the medical records, appointment registration, electronic prescriptions, laboratory orders and collect open test results, see the online health patients information. The early days of the Practice Fusion was primarily in charge mode, the brink of collapse because of profit difficulties. But the Obama administration bill requires the introduction of electronic health care system to achieve transformation, the implementation of electronic medical records and medical subsidies, the company came to life, and to establish free strategy to expand the size of the user, and thus attract investors, its current user more than 100,000 more medical records database as much as ten million copies and has been successful in several rounds of a total of up to $ 36 million financing.
Government assistance comprehensive medical information service platform
Although China has yet to have similar specific electronic medical record providers appear, but with the advantage of quick and easy, the application of information technology in China has been the growing popularity of the top three hospitals. From the People\\ s Liberation Army 309 Hospital of a case shows that when the patient\\ s condition suddenly turns dangerous, you can not back to the doctor the first time in the mobile medical workstation login through the iPad, access to workstations in the radiology records of patients, ultrasound, pathology and other imaging, ECG, monitoring, anesthesia, chemotherapy, radiotherapy, clinical diagnosis and treatment of electronic medical records and other information, real-time basis to understand the patient\\ s condition and the latest test results, issued instructions on the breathing machine, 30 seconds after the nurse had to push the ventilator to the bedside. A related statistics show that 926 hospitals surveyed, 70% have established a nurses station and other information systems in the laboratory, radiology, EKG and other key sections of the information system construction, and has been prepared to establish the proportion of respectively 66%, 60%, 48% (table).
The application of intelligent systems to simplify the work condition information transmission, integration and other aspects, the faster the patients get good relief Needless to say, but also enhance the efficiency of medical diagnosis and hospital management, granularity, and thus further enhance the hospital\\ s profitability. This is reflected in the chain of clinics on the more obvious, in view of information systems and operational ease of a high degree of replication, making the chain mode, the ability of scale and cost savings multiplied.
Generally speaking, conventional support each doctor clinic support staff of about 4-5, and by means of electronic medical records and other information, the United States One Medical Group\\ s clinics only 1.5 or less. Management to reduce operating costs while the clinic, doctors have more time to answer patient\\ s questions, the experience of both doctors and patients have been enhanced. In the profit model, One Medical support of the U.S. most insurance programs, but will charge an annual fee of $ 149-199. The company currently operates in San Francisco and New York, nine clinics, after five totaling $ 46.5 million financing, will be extended to 2011 years of its Silicon Valley and Washington, DC, opened five new clinics.
In China, most of the public hospital system is subject to the plight of the more difficult chain of copy medical information on the profitability of significant improvement is not obvious, and integrated medical information system with the ability of all levels of government, as the establishment of standards important promoter. Some of the first local government has begun to establish regional information service platform, to explore a sustainable mode of information, such as the Zhongshan municipal government on the design and planning of the trilogy, pay by the Government for the construction of regional health information service platform, and through secondary data development to attract pharmaceutical companies, health management companies; also the terminal based on personal family business, the establishment of dynamic information health records, practice management fees. It is said that this program has attracted both Huawei and other UF class enterprise software and also provoke the Legend of the Star, Oak Delin, Kun Jiuding, Xun Xiang investment venture bodies.
Although planning is still in the exploratory stage, the link is clear from the design to the actual implementation is still lagging behind, but the hospital beyond the single, integrated community-based management model may be a future trend. The next long period of time, local governments have put up the Ministry of Health is to promote health information technology will be the main force. The inter-regional cooperation to share medical information for health care resource constraints and uneven regional development in China, more efficient means to save medical resources, medical information management vision for the fine may eventually become a reality.
Rapid growth of software service providers will be
Government boost, hospitals enthusiastic early adopters, a huge growth potential has also been given information service is worth looking forward to the new space, according to IDC, by 2010, China\\ s investment in health care IT market reached 120 billion. The next five years, China\\ s health information services market will be an annual growth rate of 15-30%. CCW Research predicts that in 2011 China put into health care information technology industry, the relative total growth of 25.5% in 2010. The software services faster than hardware development, according to the GMP consulting research, the investment structure, future medical information market will further decline in the proportion of investment in hardware, software and services, while the proportion of investment will be increased year by year.
High growth is expected to attract massive capital into the industry, international companies, Intel is the number of separate parallel digital medical enterprise, mobile marketing industry, others such as IBM, Oracle (Oracle), Cisco (Cisco), are also set up a professional the medical industry sectors. Domestic manufacturers, the focus on health information technology companies listed on GEM, such as Wei-ning Software (300 253), Silver River shares (300,020), etc., have been confirmed with high growth performance of the importance of this market and prospects. Main business covers the intelligent transportation, and medical wisdom of the Silver River shares, substantial growth performance during the first half of 2011, which the wisdom of medical service revenue 72,362,900 yuan, an increase of 208.47%.
Recently, from the whole health care system integration provider cloud, down to the sub-sub-industry software provider, a new round of merger integration is surging. August 2011, Kingdee Kingdee health through the acquisition of subsidiaries Shanghai, Guangzhou, Hui Tong Computer Co., Ltd. 75% stake in the transaction consideration of approximately $ 120 million. Subsequently, Kingdee 3,000 million in cash and 26 million yuan of non-cash assets of wisdom through the capital increase, which ultimately holds 81.48% stake. Kingdee, the end of 2009, UF UF medical software through its subsidiaries an easy 18 million yuan acquisition of Guangzhou Medical Software Limited. Neusoft Group is funded at 114.1 million yuan in early 2011 acquisition of the medical industry ERP vendors look Haikang letter 73.14% stake.
Prepare business integration software vendors frequently, equipment manufacturers are also actively restructuring desire Stock Watch. As a leading global communications solutions provider Huawei, is a typical representative of cloud computing is now advertising its major sites often appeared in the medical industry, vertical, and its introduction to \"cloud the pipe end\" architecture-based package of medical information solutions, and has specific surgeon Zhabei District, Shanghai City, North Hospital, \"Health cloud\" project. With the technological edge of information technology infrastructure and network familiarity, Huawei\\ s strategy from hard to soft transition will undoubtedly inject new vitality into the market and boosting the industry a new model.
Telemedicine China Yesterday, Today and Tomorrow
Yesterday telemedicine
The early 2000s, telemedicine entering the country, beginning in 1995, Golden Health Project to promote health information technology in the construction industry, improved medical staff productivity, accelerate the speed of patient treatment, eradication of the three long, one short (registration, fees, dispensary for a long time, a doctor a short time) the shortcomings of an effective solution to the hospital fees, medicines management loopholes.
Exploration in the field of military remote military medical information network, the state established the military health project is the construction of military health system information is one of the three projects. Army won the 2004 One other scientific and technological progress awards. For remote medical consultation, skills training, remote, remote video conferencing, information retrieval library and information applications such as telemedicine for the purpose of military technology of large-scale construction of health.
\"Military Health Network\" is a military construction for the telemedicine network in achieving cross-regional comprehensive medical support, information and dissemination of results of the latest medical technology for the remote station to provide high-quality telemedicine services officers, etc., played a very important the role.
Golden Meditech network, the military health network can grasp the latest information and technology, medical technology, to enhance the strength of the hospital to address the early development of many of China\\ s remote medical problem.
Today, telemedicine
Our telemedicine began relatively late, but development is very rapid, as the core technology of telemedicine computer technology, communication technology, digital technology, medical equipment, hospital information management technologies are close to the international advanced level, with international development process, has accumulated a variety of experiences and lessons learned.
The fundamental role of the hospital information management is to improve health, reduce medical errors, reduce medical costs, it is generally accepted point of view.
In China, public hospitals funded large-scale, information technology and more beginning to take shape, and private and small and medium hospital information construction appears very weak.
Shenzhen is a specialist hospital operated for many years said, \"For private hospitals, survival is the first one, if it can not guarantee the normal operation, the other not to mention everything, so we were always fighting for the resources needed , survival is the pressure we face every day. \" Hospital information system HIS invested to meet the daily work management.
Since reform and opening, continuous development and growth of private hospitals, private hospitals health care system has become an important part. The market capacity, information technology needs, the introduction of the hardware and software updates, a huge market space! Hospital information technology applications of telemedicine, patients will bring more resources, expert resources and technical advantages.
Obviously, to make state-owned and private sharing of information has brought positive results, let the health care industry professionals from a higher altitude to get to know the hospital information construction of the benefits the country, there is a considerable of the way to go.
Future of telemedicine
With the computer technology and the rapid development of telecommunications technology, telemedicine resources can be shared, the medical exchanges can reach a higher level. In Europe, telemedicine as an important aspect of health care reform, health care in remote areas to solve the problem of inadequate resources. In Japan, the development of telemedicine, making the field of domestic and international medical meetings, tele-surgery observation, international remote transmission, etc., have reached a high level.
In recent years, telemedicine with international development. China as the largest developing country, a vast territory, large population and tends to aging, transportation, and economic conditions and the relatively backward development is highly uneven, severe lack of medical care in remote areas, to achieve universal access to health care difficult, and telemedicine in remote areas to solve this problem one of the most economical mode.
Telemedicine is a real demand, everywhere and at all times to improve medical and health care of people\\ s living standards as a new and important indicators. Continue to learn advanced technology, use modern technology to build a \"telemedicine\" in the new era.
As the American futurist Alvin Toff power years ago, predicted: \"The future of medical activities, doctors will face a computer, the screen display from a distance came a variety of information on patient diagnosis and treatment of patients.\"
With the development of IT and other new technologies, the establishment of a unified international standard system, people gradually get used to living in a world full of Internet, all for the development of telemedicine has brought new opportunities.
Medical device, “Eleventh Five-Year” this year will reach 100 billion gross domestic Yixie
Since the output value of China\\ s medical device industry since the 1990s, has maintained rapid growth, average growth rate has remained at 12% -15% level. According to the medical device industry, \"Eleventh Five-Year Plan\" of the estimated 2010 total output value of China\\ s medical equipment industry will reach 100 billion yuan.
This reporter recently held in Beijing from China\\ s medical device industry, development of high-level summit and Jieping Scientific Medical Foundation seminar on brain health experts learned.
According to experts, China\\ s medical device industry, from small to large, rapid development, has become a relatively complete product, innovation ability, the market demand is very strong sunrise industry. In recent years, the medical device industry to further accelerate the pace of development, not only the value of double-digit growth for many years, and the export volume and technological content is also rising. At the same time, we should also see the development of China\\ s medical device industry, a weak foundation, started late medical device regulation, medical device companies is small, more casual and low-level competition, the phenomenon still has not been a fundamental change, and improve China\\ s medical equipment industry, technological innovation, strengthening the capacity of medical device research and development, learning and research association, has become urgent. Experts point out that the next ten to fifteen years, China\\ s medical device industry will enter a stage of rapid development. The formation of the founding of several decades of development based on people\\ s health rehabilitation rigid requirements for medical devices, medical equipment related disciplines and technical personnel of long-term reserves, the state of medical device technology innovation, strong support, is to promote the rapid development of medical device industry to protect and power.
Jieping Medical Foundation of brain health experts, some of the medical institutions of the capital experts, respectively, on research and development of our brain health status, brain rehabilitation clinical value of brain health and brain health trends in the development of equipment to do the academic report.
Experts believe that the government and the community should attach great importance to and supports brain health research and prevention of brain diseases. Modern society, human society faces increasing competitive pressures and mental strength, so that mental illness and neurological diseases a growing threat to human health. At present, China\\ s encephalopathy is increasing. Enhance brain health research, accelerating brain health product development imperative. Experts give clear hundred monks who developed brain health OG instrument with a high rating, that the product has become the physical brain disease prevention a better choice.
Summit by the Jieping Medical Foundation, China Medical Association and co-Dade were clear of biotechnology R & D Centre.
Blue Ocean equipment for the medical device can also be leveraging Wang big market
There is a class of people, their passion for the medical devices even more than the doctors, these people are investors. They are not saving for the spirit of worship in this industry, but to break, rich mythology, high price-earnings ratio, exciting high-growth markets such as hot words rush.
However, if the big blue ocean is not without swirl device, under the sea may be calm surging undercurrent. How investors can safely steer towards a more broad area? Take a strong ship, choose a proper route, more importantly – with the wind and waves decisive and courage.
Equipment is king
The external surface of the support of a policy, within the natural growth of a strong driving force, no wonder that in the primary market, in addition to real estate professional fund, there is little PE, VC not interfere with medicine. In the secondary market, making the rich mythology of writing are mostly medical stocks.
In the pharmaceutical industry, the largest two categories of medicines and medical equipment. Among them, the medical device much favored by investors. Rainbow Medical Devices Division, General Manager, Medical Equipment Industry Corporation is China Wei Xing investment adviser, told reporters: \"In the U.S., sales of equipment and drugs, the market ratio of 1:1, while in our country, this proportion is only about 1:10 or 2:10. \"Therefore, as the level of national economic development and health, equipment room to grow bigger than drugs. \"I estimate that each year in equipment, particularly consumables should be able to reach this 20% to 30% growth rate.\" Wei Xing said.
Extension of medical devices is very large, small gauze, syringes, large CT, ultrasound, are within the scope of medical devices. According to clinical departments, such as the use of risk indicators, medical equipment division can be different, not all segments have the same investment value, development speed and capacity are not the same market.
Correct choice of segments
Wei Xing Investors are advised to take adequate attention to our library of various diseases, disease incidence, the index indicates that certain pharmaceutical products directly to the potential market size. If the incidence is very low, such as blood diseases, drugs and equipment related to the size of the market are not large; Secondly, attention and determine new technologies may have a significant impact on the industry.
Gauze, cotton, bandages and other consumables are also part of the daily use of medical devices, there are some companies doing well related to stability, sustained profitability, but the market is very limited room for growth, it is difficult to meet the general financial investors in high-speed enterprise growth requirements. Xing Wei told reporters, in addition to CT, ultrasound and other large equipment, there are three types of supplies of medical devices also have investment value, one of Cardiology; second orthopedic materials; Third, diagnostic reagents.
Heart stents
\"Now the whole domestic market, all of the stent, including Cardiology, accessories, sales of the year to reach 150 billion yuan, our national consumption of materials is estimated at 60 billion a year or so of total sales, accounting for a total of Cardiology, the four one, so this is a very large space industry segment. \"Wei Xing said.
Why can account for a small stand so much market share?
First from a high cardiovascular morbidity. Previously, the incidence of coronary heart disease in China compared to other diseases is not very high, but as living standards improve, the incidence was significantly increased. At present, the incidence of disease, the library is ranked first in cardiovascular and cerebrovascular disease, and the second is cancer, then diabetes and other chronic diseases; Second, the new technology lead to market blowout. In the medical field, as long as there is a fundamental technology appears, can not solve the problem to solve before, the instant formation of a huge market space. Implantation of cardiac stents is to address cardiovascular congestion, that is a fundamental technique of coronary heart disease; Third, economic level, the improvement of health care system, so that the public health care costs and improve their ability to withstand.
With the increase in the number of patients, utilization of new technologies to improve, in a long time, the heart stent market will maintain a high rate of natural increase.
How to market maturity?
Cardiology Devices market has grown to a relatively standardized and mature stage, the number of major companies from more than 60, reduced to no more than 10 present, of which domestic enterprises, including Shanghai minimally invasive, music universal health care (300 003), Shandong JW and so on. Imports are mainly manufacturers Boston Scientific, Johnson & Johnson, USA Medtronic Corporation.
Technically, a good domestic and imported bracket bracket gap is very small. In terms of price, according to China\\ s WTO commitments, medical equipment required by the market price, from the practical point of view, is priced by the purchaser, the hospital is the leading market-driven. Equipment prices will differ according to different manufacturers, at present, the heart stent made of four large manufacturers execution unit are ten thousand seven hundred yuan, the price of imported manufacturers implement different. To Johnson, for example, the price of each product is nineteen thousand three hundred yuan, or about twice the domestic bracket, \"spread mainly from foreign manufacturers for R & D investment is much larger than the domestic manufacturers.\" Wei Xing said.
Now, in the Cardiology market, the market share of domestic products has reached 70%. Hospitals in the mainstream of the basic cardiac stents, are based on domestic-based, supplemented by imports.
Orthopedic materials
Orthopaedic basically divided into three sections: trauma category, type of spinal, joint classes. In the domestic market, the production of orthopedic materials business more than seventy to eighty, of which, the joint production of the material is not more than ten national companies, but wound class, there is still a large number of small workshops, industry concentration is lower than the overall Cardiology. Creation Holdings, Comfort Medical is relatively good in the field of listed companies.
Orthopedics imported products and domestic product prices far. Trauma products, import parts and domestic parts of the spread is probably about double; spine products, domestic parts price is about 70% of imported parts. In technology, design, development, materials, surface treatment, etc., domestic products and imported products, there are still some gaps. For example, the Xindi Si is the world\\ s production of orthopedic trauma supplies top-ranked business class, which created the standard AO, AO products out of the body, there will be no mucus attached to the surface, while the domestic product of the treatment process difficult to achieve, But this does not affect the use of the results. As a result of quality problems caused by the broken nail broken boards, would severely affect the patient\\ s use. AO\\ s products may also happen, but the proportion is much lower than domestic products.
Current market share in orthopedic trauma class materials, the amount of domestic products over imported products, but is lower than from the total sales of imported products; joint-like material, the use of the total imports for 70% to 80% , made only a small part of the use of the product; spine class is mainly imported. Major orthopedic hospital on the choice of materials are mainly imported, domestic, supplemented.
Diagnostic reagents
Medical devices in diagnostic reagents is very different segments of the market space, domestic Kehua, Fosun, foreign Roche, are relevant listed companies.
The current chaos in this area, domestic products and imported products there is a huge gap between the price and technology. For example, the conventional two pairs of semi hepatitis B surface antibody testing, domestic products are mostly used in enzyme linked immunosorbent assay, usually costs 30 yuan per capita, but with Abbott, Roche, represented by imported products, the cost per test up to several thousand pieces. This disparity is due to the price of imported products with the use of diagnostic methods and diagnostic equipment is more advanced, you can achieve higher accuracy. In addition, since the use of biochemical methods, tests are complete, such as lung problems just want to look, but do a body check, tentatively not to comment on the need for it, but this, patients need to pay higher treatment costs in the affirmative.
In other countries, usually by charging disease, the treatment of each disease has provided the cost of the cap, as is the Medicare payment, special circumstances require more than this standard, you need health insurance approval. We do not have this national standard, and, in our country, because the existence of the chain stakeholders, health care products seems to be greater the higher the selling price set out, the health care system seems to be more conducive to the survival of expensive medical products. Therefore, the imported diagnostic reagents market in China has accounted for most of the country.
China\\ s pharmaceutical enterprises often do not attach importance to R & D, to clone, imitation-based. However, in the field of diagnostic reagents, but there is a huge barrier. \"Because the imported reagents are mostly closed, you need to use in the relevant instruments, such as biochemical analyzer, is done well abroad, we imported this machine, you must use it the reagent products and can compete to design a equipment even greater difficulty. \"Wei Xing said. In this area, our only way out R & D, but this is precisely the domestic pharmaceutical companies short board.
Only the pipe in the above three segments, the current stage of development and maturity of the market is different, but they have a big market space, growing faster than other investments that have the value of its basic characteristics.
Investment combat chapter
Both market and R & D
Medical equipment for a high-tech industries, R & D capability is important, but by no means the only lifeline. Market often heard such a voice: \"the lack of research and development of domestic pharmaceutical companies, not even research and development.\" Does this mean that the domestic pharmaceutical companies do not have the strength and the development of investment value?
Long-term commitment to investment in the field of medicine OrbiMed Wang Jian, senior managing director said: \"China\\ s enterprises in R & D investment and R & D capability is relatively weak, which in current practice, not necessarily how much of a disadvantage Because China is now a great opportunity to market and rapid growth of domestic demand, medical to second and third tier cities and rural areas to push the product in need of medical services and the large number of people, but the relatively low purchasing power in this situation, the spend a lot of money and time only sophisticated research and development, but not to seize market opportunities, and some more harm than good. \"examples from the market point of view, some companies tend to mature products, production and sales, some companies tend to innovative technology R & D, in the current China, many success stories is the former rather than latter. If the large market in the face of a company dominate the market, the ability to make a profit is more important than research and development.
However, people without finest hour, when the market more competitive, companies must be the original downward margin pressure, and when the market becomes more mature, if not technology, will be very dangerous. Wang Jian said: \"within the limits of enterprises in R & D is also necessary, should take precautions as institutional investors, and that it should invest more in more early, higher levels of technology innovation.\"
Investment real: a domestic manufacturer of orthopedic devices, the existing products in the market has grown rapidly in sales, gross profit margin is high. But with the market compared to other similar products lack of differentiation, gross margins in the future may be getting lower and lower. This company hopes to introduce institutional investors, investment OrbiMed prior to several issues of concern to them: your products and technology with other companies any different? Where art? How can you better than others after a few years? The company\\ s answer is that they have advanced technology with overseas companies and individuals have a lot of cooperation, and several leading U.S. companies have established a strategic partnership. All shareholders are also some well-known inside the industry who can bring a number of related advanced technologies. Faced with such a business, recently, there can be profitable in the market; long-term, can be imported from the West to develop the required technology. Therefore, OrbiMed the decision to invest.
More potential in the early project
Currently, the equity market is the demand exceeds supply, particularly in the pharmaceutical industry, a good business behind a number of investment institutions have coveted and coveted. Pre-IPO project to turn? Face of the extraordinarily high cost of investment, how many people can do no turning back? For most institutional investors, in order to succeed in this industry may have to hope some of the mid or even early investment projects. Warburg Pincus investment in health care for Dunlop is a relatively successful case.
Investment real: a medical product registration, should be the first clinically validated its efficacy and safety, Dunlop\\ s main product is the drug of Cardiology stents, such products usually require thousands of patients through clinical trials, and then to State Food and Drug Administration for approval, registration process takes about two to three years, when the time to get the certificate of registration to be eligible for sale in the marketplace, but that does not mean the market is fully open. In 2004, Dunlop made shortly after the registration certificate, Warburg Pincus that the PE of 10 times the market price of shares was 10 billion Dunlop, this time the risk is still huge. 10 times PE for early projects, although not low, but the initial stage in the development of business profits base is limited, simple does not necessarily mean high PE multiple of the extraordinarily high cost of investment. Just think, if China equal to Dunlop 2009 shares listed on the eve of another assault, Leaving aside can not enter the same 20% of the price of the shares at this time what should be? Warburg Pincus to greater risk Bo back to the high return on investment, with, of course, not Pifuzhiyong.
Wei Xing said: \"To vote early or mid-project, must be very aware of this industry, including the industry\\ s growth potential, but this ability often do not have a financial investor, a visionary investment company, be sure to close There is a team of professionals within the industry for support, if a PE or investment bank with such talent, I think even in the initial stages of a business can also vote, so the success rate is relatively low, but the payoff is huge. \"
Not short of money companies have investment opportunities
In the pharmaceutical industry, good business no shortage of funds is a very common situation, this means that it did not finance motive, investors no chance? Not. The development of enterprises often need outside funding in addition to a wide range of support, such support is sometimes the money can not buy, such as networks, channels and resources.
Investment real: a manufacturer of surgical instruments of domestic manufacturers in the Chinese market, it is one of the largest market share, and in Europe, Africa and Asia, some countries also have good sales, the daily cash flow from operations is sufficient . But the company still hopes to introduce institutional investors to become shareholders. The reason is that in this area, the United States is the largest market, therefore, he hopes to enter the U.S. market, but U.S. sales channels, brand building, the idea of ??local doctors, how to recruit staff and other specific issues that are very strange ; Second, the company has the intention of overseas listing; Third, business leaders themselves are not industry experts, to this point is not easy, deep down will be more professional, more and more high-tech, more and more difficult, therefore, he hoped to find such an investor – are familiar with the U.S. market and market channels, and can provide him with experience in professional and technical support.
In addition, \"no shortage of state funds only for a certain stage, but there may be the next stage of development in the next step in the implementation of the plan, will surge in the demand for capital and some future prospects of business financing is not necessarily clear understanding, therefore, investment institutions have appropriate guidance and advice. \"Wang Jian said.
Investment risk medical devices
Corporate risk team
Wang Jian said: \"The team is often the biggest investment risk lies.\" Good management team in any company and any industry which plays an important role. Perfect plan, advanced technology, the markets have decent, but not if the team, eventually will fail. And, often determines the quality of personnel is not only the level of qualifications, working experience, not even professional background, but the direction of enterprise development teams can have a clear understanding, as well as strong and durable execution.
Market risk
Investment in medical devices, under normal circumstances, it is best to cast a lot of operational projects, many patients are needed, will have a very bright future. And in considering the size of the market, we must refine the project directly to seize the market. In the end what was the size of investment value? Wang Jian said: \"If a company\\ s products in the worldwide market size may not exceed $ 500 million or 40 billion yuan, in normal circumstances would not consider investing in this company in a small pond is no way to support a dragon. \"
Technical risk
Medical product development cycle is longer, money demand, inevitably there is a big technical risk. \"But for investors, does not need to blindly search for sophisticated technology, is important for today\\ s market is looking for technical.\" Wang Jian said.
Out of risk
Investment in other sectors, like the ability to achieve safe exit? What price to exit? Investment project are to determine whether an important indicator of success. Wang Jian said: \"The medical field of venture capital, usually two to seven years, most of them in between three to five years you have to determine in a few years ago the company\\ s future ability to exit through listing or acquisition is difficult, many factors not under our control. \"
For the market, the basic risks: business turnover, profit after a certain period of time, can achieve the minimum listing requirements; or there may be some special reasons, the market channel is closed, such as the 2008 to 2009 financial crisis.
M & A risks, such as: can not find a suitable buyer. In particular there are a number of industry turnover of enterprises and products are similar. But if your product is just a big company\\ s product line in the relatively short piece, or with a large company is a direct competition, it was a great likelihood of mergers and acquisitions.
Corporate re-financing risk
Some of the industry requires a lot of financial support, including research and development. The company\\ s future financing capacity is not strong, the channel is not smooth, investors will enter the pre-pose a great risk. Example, only 500 million investment to support R & D progress to a certain stage, the subsequent demand for funds may be 50 million, if the corporate finance 50 million less than this, it means that 500 million early investment will completely fail.
New growth of medical electronics market: neural implant devices
Create a new company called NeuroPace want to get the first nerve implanted device sales license. NeuroPace work only burgeoning field of neurological devices market surge in miniature.
NeuroPace company in July this year will be used to treat epilepsy, a brain implant device sent to the U.S. Food and Drug Administration approval, the product has been a decade of research and development. NeuroPace RNS companies want their system to be allowed to use within a year.
NeuroPace Chief Medical Officer Martha Morrell in BioMedDevice Forum, said: \"I believe in the next decade, a variety of closed-loop, open loop brain stimulation devices will replace destructive surgical therapy.\"
Epilepsy implanted devices allow researchers an insight into the trial of this technology in the treatment of serious illnesses when the potential scope of coverage possible from pain, depression to Parkinson\\ s and Alzheimer\\ s disease, including a variety of diseases.
Morrell said: \"This is our first in-depth observation of real-time changes in the brain, we treat it as a disease management tool.\"
NeuroPace\\ s RNS implanted device has two home-made chips, found in epilepsy patients with abnormal brain activity is more severe than previously predicted.
Morrell said: \"never had before the diagnosis of epilepsy for the record, the results show that the disease attacks only the tip of the iceberg, we found that these patients require up to 600 times a day to stimulate, 1-2 minutes long each time.\"
Doctors can program the device, making it the status of a variety of perception and response. NeuroPace maintains a database that can be used for long-term study of brain wave activity.
Morrell said the potential of such devices is that the brain can release traces of the target area on the drugs, the current stimulus. The new electrode sensors can extend the entire column and the application of the symptoms of such equipment. In addition to other brain waves, researchers are still studying cerebral blood flow, oxygen, neurotransmitters as well as temperature changes, in order to analyze the disease.
Opportunities and Challenges
According to market analyst firm NeuroInsights analysis, neurological devices market value of about 70 billion U.S. dollars, annual growth of 15%.
NeuroPace the market value of such neurological implantable devices accounts for 23 billion U.S. dollars, annual rate of 14% by Zhang. The share of neurological surgery equipment up to 35 billion U.S. dollars, the annual growth rate of 17%.
Although venture capital investment in poor overall situation in the field of health care is not good, but very strong in the field of neurological devices. In 2009, the neurological technology to obtain 15.8 billion dollars in venture capital, compared with 2008 increased by 9%. Life sciences over the same period the total amount of investment is in decline.
Worth the investment of the company a lot. New companies NeoStim looking through a non-invasive way of deep brain targets within the electromagnetic stimulation, in order to alleviate the severe symptoms of depression. NeoStim Chief Medical Officer M. Brett Schneider said the technology will be extended to other areas of the brain, can be used to treat Parkinson\\ s disease, pain and anxiety.
Trifectas company is developing an implantable medical technology to help stroke patients recover. The technique uses electrical stimulation of multiple areas of the brain, helping the growth of neurons and hormones, reduce inflammation.
Trifectas company CEO Reese Terry said that every year 80 million patients suffering from stroke in half to become a trial of this equipment were.
NeoStim\\ s Schneider said he is optimistic about the way Reese choice, he said: \"It\\ s like the more muscle the more stronger with the sheets, like neurons were stimulated after the new president of the axons and dendrites, which for stroke patients is the well-being of different people without the disease also help. \"
These new devices are also facing many challenges. The researchers linked by high-resolution EEG activity and regional cerebral symptoms, but this technology is very expensive and time-consuming.
For example, Orasi Medical has developed a modeling software to use with the MEG device. MEG instrument can detect brain the size of one square centimeter area of ??activity every millisecond. However, this system is extremely sensitive superconducting devices must be stored in liquid nitrogen, the component cost as much as $ 2 million. And the instrument must be shielded MEG room use, the construction cost up to $ 500,000.
Orasi CEO Shawn Lyndon at the meeting, said: \"We have the technology (MEG) is very interested in miniaturization, it is best to make the test done in a doctor\\ s office.\"
Shawn Lyndon: seek a more powerful and cheaper MEG technology
NeoStim\\ s external electromagnetic stimulation devices are based on relatively older technology, using a large capacitance and high power switching thyristor. Schneider said: \"The new and original material should make the process of aggregation and release energy more quickly.\"
Brain implant devices need better batteries and more powerful, more secure way to ensure that energy to reach the organization and will not burn them. Schneider said a Stanford lab is trying to use the LED light to trigger neural activity.
On a practical level, researchers are still not clear which patients will respond to treatment facilities, and even do not know how to accurately measure the effect of continued treatment. Trifectas\\ s Terry said: \"Each region needs test, which requires several years of effort and a lot of money, but here there is great opportunity, because the human body through the energy to work.\"
New optical microscope can see cell protein
U.S. researchers said they first developed a way to observe the protein at the molecular level, the new optical microscope, cells will help scientists to explore the depths, to understand the basic organization of its internal structure.
It is reported that new optical microscope by the U.S. Howard Hughes Medical Institute and the National Institutes of Health (NIH), researchers at Florida State University s National High Magnetic Field Laboratory with the help of developed, it will help basic cell biological science research. National High Magnetic Field Laboratory optical microscopy • Team Leader Michael Davidson said that with the new microscope technology, it will be opened at the molecular level the intracellular dynamics of the mystery of an important tool.
New optical microscope is called photosensitive localization microscopy, electron microscopy it can only show up in the tiny cell structure can not see the lack of protein distribution. NIH researchers said that if the two combine, they have a more powerful, people can understand cell structure and protein distribution.
The idea of a new optical microscope, Howard Hughes Medical Institute, by the two physicists Eric • Beit Ha Zige and Ruo De Geus suggested that they encountered in the design process problems, Davidson team final help them develop a more perfect microscope. Hess said, NIH researchers found a new use of micro-UV-emitting fluorescent proteins to molecules, then, Davidson team in the laboratory of the fluorescent protein was genetically modified, and its integration with the natural protein, This is equivalent to study of each protein labeled.
For photosensitive localization microscopy work, the researchers said, they first need to study the molecular to each marked with fluorescent tags, and these molecules were irradiated with UV trace, UV activated fluorescent protein molecules, resulting in light, fluorescence can then be generated with a microscope to capture images. In this study, the above process is repeated thousands of times, each time repeating capture were only part of the protein molecule. When the protein molecules to form the overall image, it electron microscope images obtained with the biggest difference is that you can control the contrast of the viewing area.
“Second five” medical information about the size of 80 billion
New medical information is accompanied by a long-term health reform, ongoing process. In the future, in addition to the traditional medical records, the patients in the medical treatment when there will be an electronic medical records in the register. Electronic medical records will become the second phase of the new medical reform one of the priorities.
Recently, in order to ensure that our electronic medical records as the core of hospital information technology work smoothly, the Ministry of Health issued \"electronic medical record system function application level grading methods and standards\" (hereinafter referred to as the \"standard\"), will have implemented electronic medical records evaluation of medical institutions, the evaluation system is divided into eight.
Electronic medical records, also called computerized medical record system also known as computer-based patient records, it is the electronic equipment (computers, health cards, etc.) conservation, management, transmission and reproduction of digital patient medical records, to replace handwritten paper medical records. The future, patients see a doctor and check the results are available through a card, all hospitals to achieve interoperability.
\"Standard\" display, electronic medical records the highest level of medical institutions, must be patient clinics in various medical institutions records, personal health information integration, a complete electronic medical records; the same time, but also between medical institutions and residents to achieve electronic health records information exchange and sharing.
At the recent \"Ministry of Health grading electronic medical record training sessions\" on the Ministry of Health, Medical Administration Director Jiaoya Hui, this year is the new medical reform objectives and tasks for three years last year, electronic medical records, health records and other residents of the implementation will need After evaluation, it will be the next round of medical reform goals priorities.
Ministry of Health as early as last October, had issued a circular selection in the country at least 50 pilot hospitals and three pilot areas to undertake pilot work of electronic medical records, explore the establishment of suitable conditions of our country\\ s electronic medical records system. Among them, the selection of Beijing, Shanghai, Jiangsu, Zhejiang, Anhui, Fujian and other provinces as the designated 22 pilot provinces, and specify the 29 hospitals and three regional Health Ministry as pilot units and electronic medical records pilot area. Designated pilot provinces provincial health department and then the selection part of the three hospitals as electronic medical records pilot hospitals.
Medical information, and will effectively improve the operational efficiency of public hospitals, the rational allocation of medical resources, a relief \"difficult and expensive,\" an important tool. According to reports, is expected to \"second five\" medical information about the market size of 80 billion.
Hunan average price of essential medicines 57% down two down two liters of primary health care
This year a new round of bidding and drugs have been known to the public the results of the recent, successful pharmaceutical product regulation 947, the initial estimates, bid prices of essential drugs in our province before the implementation of essential drug system, the average retail price fell 57%.
Province since the Ninth Party Congress, benefit the health of our province to accelerate the pace, and vigorously promote the deepening medical reform. Basic drug system is deepening medical reform one of five key tasks, the province from January 31, 2010 start in batches, to June 20 this year, the province of all government-run primary health care institutions (2309 township hospitals, 238 community health service centers) Full implementation of the system of essential drugs and essential drugs zero sales slip.
A total of 505 kinds of essential drugs in our province, the implementation of the provincial units of centralized purchasing, respectively, in December 2009 and September this year, the organization of two centralized bidding and procurement of essential drugs, basic medical and health institutions through the bidding and purchasing network provincial drug procurement of medicines by the drug distribution business uniform distribution. In order to guide the masses to change the drug habit, the province will also include essential drugs new rural cooperative medical care, medical insurance for urban workers and residents in the scope of Medicare reimbursement, reimbursement was significantly higher than non-essential drugs.
Implementation of the basic drug system, the province s primary health care institutions showing a "two up, two down": outpatient visits increased by 23.26%, 10.24% increase in hospital visits, outpatient costs down times were 22.92%, times were 20.75% decline in hospital costs. Implementation of essential drugs, especially the grassroots zero sales slip, the large prescription drug abuse and significantly reduced, not only to reduce the mass medication burden, and promote the rational use of medicines, medication safety. Beginning next year, the province set up all required to implement village health essential medicines zero sales slip, people will have access to basic medicines system to bring more benefits.
Authoritative comment
Xiao policy group (party secretary of the provincial health department)
To well-off, the first health. Public health protection is one of the most important livelihood. As health care reform is an important reform, national essential medicines system "prove safety," your doctor for treatment, "chronic." This is a brand new system, but also solve the primary care health facilities deep-rooted problems of fundamental measures. The province to achieve full coverage of basic drugs, let the people enjoy the most direct, more affordable, primary health care institutions showing a "two up, two down," the fortunate situation.
Implementation of the national health system in our province with an opportunity for basic drug system, focusing on institutional innovation, the flow, to tackle tough, grass-roots health care institutions to carry out the management system, personnel system, distribution system, the basic drug system, financial security system comprehensive reform, the progressive realization of "the government was popular, people may benefit, was the development of health" reform goals.
Stem cells to the heart of micro syringe injection
New design of a micro-syringe can be adjusted to the heart through the coronary arteries of patients transported their own adult stem cells to treat heart disease damage.
The so-called micro-adjustable syringe containing a C-type balloon, when inflated balloon, then push the needle into the microinjector coronary artery wall and perivascular stem cells injected into the tissue. Studies have shown that autologous bone marrow stem cells into the heart can help treat heart damage, improving blood flow and shrink the scar.
According to the developer, said syringe, enter the number of stem cells and treatment of the observed effect is directly proportional to the response between the recommended amount of injected stem cells will be more to promote faster recovery. Direct injection method to prevent the blood flow away stem cells. The micro-syringe by the American California\\ s EndoBionics, the company developed.
EndoBionics, the company\\ s executive vice president Robert Cafferata, Ph.D said, \"with micro-syringe delivery of stem cells in the artery just sent to the outer surface, so that stem cells deposited on oxygen and blood areas, so fortunate as the critical cells.
Medical equipment will be a special plan for future growth 20%
Authorities from the Ministry of Science and was informed at the exclusive, special focus on Science and Technology \"medical device Industry and Technology Development Plan 2011-2015\" has been completed, to solicit the views of medical device companies are expected to introduce in the near future.
According to Ministry sources, the \"five-second\" period, China will greatly enhance the number of medical devices, intelligent, high precision and networking, to promote the development of domestic medical equipment, the next step is also expected to achieve in the field of medical devices and then manufacturing.
Ministry sources, the \"special plan\" for each high school to support low-end medical equipment. The focus of primary care involves basic equipped with 10 categories, and is expected to promote the appropriate conditions of inexpensive high-quality ultrasound ultrasound equipment; in high-end products focused on solving the problem of high-value consumables, and strive to achieve the pricing; medical services will be supported.
The source said that since 2008, China launched a national medical device industry research, the basic information currently available. The current domestic medical device industry is characterized by: small quantities, but the profit margin is high; products are public goods, property, belonging to the Government pay range; distinctive characteristics of high-tech industry sectors, innovation is very fast, get the policy of great concern.
China Medical Device Industry Association Expert Committee Wang Xiaoqing, said medical device development is now showing a trend of integrated development, corporate sales will not only equipment, but the integrity of services and comprehensive solutions, home medical equipment, surface to primary health care equipment and medical devices based on wireless networks and so may gain a larger market.
It was explained that the hospital is not a major grass-roots community organization of medical diagnosis, but the future operation of the rehabilitation process of the main executive body, therefore, home medical equipment is expected to seize a beachhead in the community hospital.
Medical device industry scattered, chaotic features the same attention. Mindray Bio-Medical Electronics Co., Ltd., Hang Xu, China\\ s total number of medical device companies a total area of ??about 14,000, but sales of more than 1 billion less than 200 enterprises. Industry shows that high-tech, multi-disciplinary, complex production process, as well as mainstream SMEs, big gap between the overall strength of the status quo. However, the global market, 70% of medical equipment sales focus on the first 30 companies in the hands.
Secondary market, the investment value of the medical device industry is also promising. 10 medical device sector contrarian outstanding performance, Improve Medical (300,030 valuation, assessment, market, information, main trading) (300,030 valuation, assessment, market, information, the main trading), nine medical safety (002,432 valuation, evaluation, market, information, main trading) (002,432 valuation, assessment, market, information, the main trading) limit two stock, music universal health care (300,003 valuation, assessment, market, information, main trading) (300,003 valuation, assessment market, information, the main trading), diving medical (002,223 valuation, assessment, market, information, main trading) (002,223 valuation, assessment, market, information, the main trading) and others doing well.
Minsheng Securities Research, said the domestic demand for medical devices is getting better, and downward pressure on prices is small, with the new rural cooperative medical insurance co-ordination to increase the proportion of urban residents, patients will become more accurate diagnosis requires a high, strong demand for various types of diagnostic equipment.
It is understood that the current height of the domestic low-end test equipment has passed, the field of foreign high-end equipment, absolute advantage, high-quality home medical equipment company is expected to become a good investment targets.
Comments: Minsheng Securities Research, said the domestic demand for medical devices is getting better, and downward pressure on prices is small, with the new rural cooperative medical insurance co-ordination to increase the proportion of urban residents, the exact diagnosis of patients require increasingly high demand for various types of diagnostic equipment strong.
Future of the industry a 20% compound growth medical device market leveraging the Blue Book
October 31-November 3, the 66th China International Medical Equipment (Autumn) Fair (CMEF) was successfully held in Fuzhou.
\"2011 annual report of China\\ s medical industry\" blue book came out, the \"Blue Book\" by Reed Sinopharm CMEF together world-renowned consulting firm Frost & Sullivan took six months to complete, is the most recent influential Chinese medical industry, a research report. Because of them predict the future of China\\ s medical device industry will be rapid growth, which led to the recent medical device market.
Forecast 20% compound growth of the industry\\ s future
According to the \"Blue Book\" described in the next five years, China\\ s medical device industry, the three main driving factors: First, the national \"five\" plan to encourage social capital to enter the health care field; Second, the new medical reform plan to phase out hospital drug addition , hospital charges for medical services will become the main source of income, the hospital will increase investment in medical equipment; third, according to national \"five\" plan, the new focus on medical and health resources to the rural and urban communities tilt, which makes low-end medical equipment market needs to expand the domestic enterprises in particular.
Another driving factor is: First, some domestic high-quality medical device companies have listed, on the one hand regulate the operation of enterprises, on the other hand can contribute to new product development through financing and the establishment of overseas markets; Second, the Chinese medical device market share in China 14% of the pharmaceutical market, while the global medical device market share of the total pharmaceutical market size ratio of 42%, which means that the Chinese medical device market is still much room for development; Third, China\\ s urbanization process and the acceleration of the aging population, resident self-care awareness, increase public awareness of medical and health services.
Based on the above factors, the \"Blue Book\", said the next five years, China\\ s county-level hospitals for medical imaging equipment, testing equipment and information technology equipment demand will increase significantly, and forecasts, 2011 to 2015 China\\ s medical device industry compound annual growth rate could reach 20.1%.